Dr. Donald Charles Vile, MD

Dr. Vile practices at Blue Ridge Cancer Care in Roanoke, Virginia.

Dr. Vile's NPI, 1366862484, was assigned on April 16, 2014. Dr. Vile holds Virginia license 0101268376.

Dr. Vile's primary practice is Blue Ridge Cancer Care, at 2013 Jefferson SW St, Roanoke, VA 24014 in Roanoke City. The practice phone is (540) 982-0237.

Dr. Vile's primary practice is Blue Ridge Cancer Care in Roanoke, Virginia. Dr. Vile is also affiliated with Carilion Roanoke Memorial Hospital. The medical group on file is Blue Ridge Cancer Care. Dmand AI also links Dr. Vile to 4 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vile practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Vile's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Vile's licenses on file in 2 states: Virginia and North Carolina.

CMS data shows 55,190 Medicare services from Dr. Vile across 60 procedure codes in 2024, for 639 Medicare patients. Medicare paid $1,348,774 for them.

CMS counts 639 Medicare patients who saw Dr. Vile in 2024. The largest group is 65 to 74, with 292 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 2.04, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Vile's median patient age at 69, with 55% women.

In 2024, Dr. Vile wrote 1,262 Medicare Part D claims for 182 patients. 79% of them were for generic drugs. CMS names the drug for 1,026 of them, across 34 drugs with 11 or more claims each, at $2,270,929 in total drug cost. In 2023, CMS named 1,038 claims across 33 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Vile for performance year 2024, reported through an alternative payment model (APM). Dr. Vile accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Vile in 2013. Dr. Vile's most frequent co-authors are Safoa Afua Addo, MD, Rhonda L. Bitting, MD and Michael Goodman, MD.

CMS Open Payments shows 36 general payments to Dr. Vile from 14 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 66% of the total. Novartis Pharmaceuticals Corporation paid the most, $296.